Global Umbilical Cord Blood and Tissue Storage Service Market Strategic Research Report

Scope of the Report

The global Umbilical Cord Blood and Tissue Storage Service market size is predicted to grow from US$ 16,390 million in 2025 to US$ 32,719 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Umbilical cord blood and tissue storage refers to the aseptic collection of umbilical cord blood and tissue after birth, followed by testing, separation, cell processing, and cryopreservation in liquid nitrogen for long-term storage of the rich hematopoietic stem cells, mesenchymal stem cells, and other cell resources with regenerative medicine value. Umbilical cord blood primarily contains hematopoietic stem cells, which can be used to treat diseases such as leukemia, lymphoma, aplastic anemia, and thalassemia. Umbilical cord tissue is rich in mesenchymal stem cells, with broad application potential in tissue repair, immune regulation, and regenerative medicine. Storage models include public banks, private banks, and hybrid models, serving families, hospitals, research institutions, and cell therapy companies, and is an important component of the cell therapy and precision medicine industry.

With the development of stem cell therapy, regenerative medicine, gene therapy, and precision medicine, the umbilical cord blood and tissue storage industry is gradually transforming from traditional "bioinsurance" to a cell resource platform and regenerative medicine infrastructure. Currently, umbilical cord blood is used to treat more than 80 diseases, and clinical research on mesenchymal stem cells derived from umbilical cord tissue continues to increase in the fields of neurodegenerative diseases, diabetes, autoimmune diseases, cardiovascular repair, and tissue engineering. With the development of CAR-T therapy, induced pluripotent stem cell (iPSC) therapy, exosome therapy, and personalized medicine, the demand for umbilical cord tissue storage is expected to grow faster than that for traditional cord blood storage. The Asia-Pacific region, particularly China, India, and Southeast Asia, will be the fastest-growing market, while the construction of public banks, long-term storage services, and the commercialization of cell therapy will drive the industry's continued expansion.

This report presents a comprehensive overview of the global Umbilical Cord Blood and Tissue Storage Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Private Banks
• Public Banks
• Mixed Banks

Segment by Operating Models

• Umbilical Cord Blood Storage
• Umbilical Cord Tissue Storage
• Placement Tissue Storage
• Amnion Tissue Storage
• Multi-Tissue Combined Storage

Segment by Cell Types

• Hematopoietic Stem Cells
• Mesenchymal Stem Cells
• Endothelial Progenitor Cells
• Others

Segment by Application

• Blood Diseases
• Immune Diseases
• Nervous System Diseases
• Genetic Metabolic Diseases
• Congenital Diseases
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Umbilical Cord Blood and Tissue Storage Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Blood Diseases, Immune Diseases, Nervous System Diseases evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact